None listed
Conditions
Interventions
Drug : Patients were randomly distributed to Clopidogrel and Aspirin arms after implantation of zotarolimus-eluting stent (Onyx family) and will take the assigned drug after 1-3 months of dual-antipla
Sponsors
Yonsei University Health System, Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients = 19 years-old. 2. Patients who received zotarolimus-eluting stents (Onyx family) implantation for ischemic heart disease 3. Provision of informed consent
Exclusion criteria
Exclusion criteria: 1. Patients = 85 years-old. 2. Acute myocardial infarction. 3. Left main bifurcation lesion requiring 2-stent technique. 4. Pregnant women or women with potential childbearing. 5. Life expectancy < 1 year. 6. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator. 7. Inability to understand or read the informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Net advese clinical outcomt (NACE, composite of all-cause death, myocardial infarction, stroke and major bleeding (BARC 2, 3 or 5)) | — |
Secondary
| Measure | Time frame |
|---|---|
| Each components of NACE (all-cause death, myocardial infarction, stroke and major bleeding (BARC 2, 3 or 5));Total ischemic event (all-cause death, myocardial infarction, stroke);Cardiovascular death (Defined as any death not due to any other apparent cause, such as cancer, infection or trauma);Stent thrombosis (including definite and probable stent thrombosis);Target vessel revascularization (Revascularization of vessels treated at the time of study enroll);Target lesion revascularization (Revascularization of lesions treated at the time of study enroll) | — |
Countries
Korea, Republic of
Contacts
Public ContactYong-Jun Lee
Yonsei University Health System, Severance Hospital
Outcome results
None listed